Your cart is empty.

The Most-Trusted Regulations & Guidelines Books on the Market.
Celebrating 19 Years of Excellence.

Now shipping orders for our APRIL 1, 2021 Books

Book 3C:  2021 The Official Investigator's Handbook for Conducting Cancer Clinical Trials

Book 3C: 2021 The Official Investigator's Handbook for Conducting Cancer Clinical Trials

$ 15.95

Return to Previous Page

This spiral-bound, 5.5" x 7.5" book is a compilation of documents from various US government cancer research divisons developed to assist investigators and their site staff on conducting cancer clinical trials.  It includes such topics as:

• How to write a cancer clinical trial protocol
• Developing an informed consent form
• Reporting adverse events

It also includes the latest Common Terminology Criteria for Adverse Events (CTCAE).

What's the Price?
• 1-249 copies:  $16.95             • 250-499 copies:  $15.95
• 500-749 copies: $14.95          • 750+ copies:  $13.95

Custom Cover Prices*?
• 1-24 copies:  unavailable             • 25-100 copies:  $2.00/book
• 100-249 copies: $1.00/book        • 250+ copies:  No charge

* Based on quantities of a single book title

•  A Handbook for Clinical Investigators Conducting
Therapeutic Clinical Trials Supported by CTEP, DCTD, NCI
      2014 (Version 1.2)

•  Letter of Intent Instructions
      NCI/CTEP Career Development

Components of a Competitive Letter of Intent
      Investigational Drug Branch, CTEP, DCTD, National Cancer

•  Protocol Authoring and Submission Guidelines Handbook
      NCI/Cancer Therapy Evaluation Program

•  NCI Consent Form Template for Adult Cancer Trials
      Version Date May 12, 2013

•  NCI Guidelines For Investigators: Adverse Event
   Reporting Requirements For DCTD (CTEP and CIP) and
   DCP INDs and IDEs

      Effective September 16, 2013

•  NCI Guidelines For Auditing Clinical Trials for the NCI
   National Clinical Trials Network (NCTN) Program,
   Community Clinical Oncology Program (CCOP)/NCI    Community Oncology Research Program (NCORP) and    Research Bases

      Clinical Trials Monitoring Branch, Division of Cancer Treatment
       and Diagnosis, National Cancer Institute

•  Common Terminology Criteria for Adverse Events

      Version 5.0, Published: November 27, 2017
      U.S.Department of Health and Human Services, National
      Institutes of Health, National Cancer Institute

Click here to see an enlarged pdf cover